{
  "meta": {
    "title": "00119_Mid_Day_Module_Pyqs_Mixed_Bag-16",
    "url": "https://brainandscalpel.vercel.app/00119-mid-day-module-pyqs-mixed-bag-16-2d060b9a.html",
    "scrapedAt": "2025-11-29T18:13:09.183Z"
  },
  "questions": [
    {
      "id": 10183,
      "choices": [
        {
          "id": 40698,
          "text": "<p><span style=\"font-size:12.0pt;\">Light microscopy shows effacement of podocytes</span></p>"
        },
        {
          "id": 40699,
          "text": "<p><span style=\"font-size:12.0pt;\">Good response to steroids</span></p>"
        },
        {
          "id": 40700,
          "text": "<p><span style=\"font-size:12.0pt;\">Most common in adults</span></p>"
        },
        {
          "id": 40701,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-selective proteinuria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old presents with edema and anasarca. A diagnosis of minimal change disease is made. Which of the following is true about this condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q9955075",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506502,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"color:black;font-size:12pt;\"><strong>Ans. B) Good response to steroids</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">Minimal change disease (MCD) is a type of glomerulonephritis that typically affects children and is characterized by the presence of nephrotic syndrome. The following statement is true about this condition:</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\">Good response to steroids: MCD is often considered to be the most steroid-responsive form of nephrotic syndrome. The vast majority of children with MCD respond well to treatment with corticosteroids, with complete remission of proteinuria and edema occurring in over 90% of cases. However, the response to steroids may be less predictable in adults with MCD.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option A. Light microscopy shows effacement of podocytes</strong>: Electron microscopy shows nonspecific obliteration of epithelial foot processes (not light microscopy)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option C. Most common in adults</strong>: it is common in pediatric age group, not adults</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option D. Non-selective proteinuria</strong>: the patient will have massive nephrotic range proteinuria.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">The causes of MCD are mostly idiopathic. It is usually associated with Hodgkin's lymphoma (due to the increased production of cytokines), respiratory infections, prophylactic immunizations, eczema, and rhinitis.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture145.jpg\" alt=\"\" width=\"400\" height=\"341\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinically, they mostly present with proteinuria. The child presents with a history of edema that is initially noted around the eyes and gradually progresses into generalized edema. Hypertension and hematuria are uncommon.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture146.jpg\" alt=\"\" width=\"1000\" height=\"422\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Minimal change disease (MCD) is the most common cause of nephrotic syndrome in children and has a very good response to corticosteroid treatment, resulting in complete remission of proteinuria and edema in over 90% of cases.</span></p>",
      "correct_choice_id": 40699,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10243,
      "choices": [
        {
          "id": 40938,
          "text": "<p><span style=\"font-size:12pt;\">Yellow fluorescence</span></p>"
        },
        {
          "id": 40939,
          "text": "<p><span style=\"font-size:12pt;\">Coral red fluorescence</span></p>"
        },
        {
          "id": 40940,
          "text": "<p><span style=\"font-size:12pt;\">Blue fluorescence</span></p>"
        },
        {
          "id": 40941,
          "text": "<p><span style=\"font-size:12pt;\">Green fluorescence</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a diabetic patient, the following lesions are present in the armpit. What would be observed during a Wood's lamp examination?&nbsp;</span>(INICET NOVEMBER 2022)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13579.jpg\" alt=\"\" width=\"300\" height=\"224\"></p>",
      "unique_key": "Q5268184",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506509,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Coral red fluorescence.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The clinical scenario of a <strong>diabetic patient</strong>, along with the observed <strong>hyperpigmented </strong>lesion in <strong>axilla</strong> strongly suggests e<strong>rythrasma</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Coral-red fluorescence under Wood's lamp examination&nbsp;</strong>is the characteristic finding in this disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture20.jpg\" alt=\"\" width=\"400\" height=\"224\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Erythrasma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is a skin infection caused by <strong>Corynebacterium minutissimum</strong>. This condition is commonly seen in individuals with diabetes and weakened immune systems and is associated with factors such as <strong>obesity, excessive sweating, and poor hygiene.</strong></span></li><li><span style=\"font-size:12pt;\">The characteristic feature of erythrasma is the <strong>presence of hyperpigmented patches that are typically asymptomatic.</strong> These patches commonly appear in areas like the <strong>axilla, groin, intergluteal, and sub-mammary regions.</strong></span></li><li><span style=\"font-size:12pt;\">The <strong>coral pink fluorescence observed during Wood's lamp examination</strong> is a defining feature of erythrasma and is caused by <strong>coproporphyrin III</strong>, a pigment produced by the <strong>bacterium</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture21.jpg\" alt=\"\" width=\"300\" height=\"249\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Wood's lamp uses ultraviolet wavelength light at <strong>365nm (320-400nm)</strong> with a peak at 365nm. <strong>The filter of the Wood's lamp is composed of Barium silicate and 9% Nickel oxide.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Yellow fluorescence:&nbsp;</strong>Often seen with <strong>Pityriasis versicolor</strong>, which fluoresces yellow or apple green due to the presence of tryptophan metabolites produced by Malassezia species.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Blue fluorescence:&nbsp;</strong>Not commonly associated with bacterial or fungal infections of the skin but may appear in certain conditions unrelated to common skin infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Green fluorescence:&nbsp;</strong>Typically observed with <strong>Pseudomonas infections</strong> or some cases of <strong>Tinea capitis</strong> caused by fungi that produce substances that fluoresce green.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Table: Various diseases &amp; their colour on woods lamp examination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-175903.jpg\" alt=\"\" width=\"1000\" height=\"422\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture22.jpg\" alt=\"\" width=\"300\" height=\"211\"></strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture23.jpg\" alt=\"\" width=\"400\" height=\"166\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-182645.png\" alt=\"\" width=\"500\" height=\"228\"></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">The <strong>Wood's</strong> lamp uses <strong>UVA</strong> light with a wavelength of <strong>365nm</strong> (<strong>320</strong>-<strong>400</strong> nm) for the diagnosis of various skin conditions based on the <strong>fluorescence</strong> characteristics of the skin under this specific range of ultraviolet light.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition volume I Chapter 4 page no 4.20</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rook's Textbook of Dermatology -9th Edition, Chapter 26 Page no 26.40</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Image source: </strong></span><a href=\"https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg\"><span style=\"font-size:12pt;\"><strong><u>https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg</u></strong></span></a></p>",
      "correct_choice_id": 40939,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47867,
      "choices": [
        {
          "id": 191063,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">50</span></span></span></span></p>"
        },
        {
          "id": 191064,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100</span></span></span></span></p>"
        },
        {
          "id": 191065,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">150</span></span></span></span></p>"
        },
        {
          "id": 191066,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">300</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A chorionic villous sampling is done at 12 weeks in a woman whose blood group is B negative. Her husband&#39;s blood group is A positive. What is the dose of Anti D given?&nbsp;(FMGE JANUARY 2024)</span></span></span></span></p>",
      "unique_key": "Q8306486",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506511,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 50</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case of Rh incompatibility, where the mother is Rh-negative (B negative) and the father is Rh-positive (A positive), there is a risk of fetal-maternal hemorrhage (FMH) during invasive procedures like chorionic villous sampling (CVS). This can lead to the mixing of fetal and maternal blood, potentially causing the mother to form antibodies against the Rh-positive fetal red blood cells. To prevent this alloimmunization, an Anti-D immunoglobulin injection is administered.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The standard practice is to give Anti-D immunoglobulin during any inciting event (e.g., CVS, amniocentesis, abdominal trauma, abruption, placenta previa) and at delivery. Additionally, it is given prophylactically at 28 weeks of gestation to all Rh-negative women.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The dosage of Anti-D depends on the gestational age:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-125324.png\" style=\"height:651px; width:400px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Less than 12 weeks: 50 micrograms intramuscularly.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More than 12 weeks: 300 micrograms intramuscularly.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since the CVS was performed at 12 weeks, the appropriate dose of Anti-D is 50 micrograms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For Rh-negative women undergoing an inciting event like chorionic villous sampling at less than 12 weeks gestation, the dose of Anti-D given is 50 micrograms.</span></span></span></span></p>",
      "correct_choice_id": 191063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24775,
      "choices": [
        {
          "id": 99061,
          "text": "<p><span style=\"font-size:11.0pt;\">25</span></p>"
        },
        {
          "id": 99062,
          "text": "<p><span style=\"font-size:11.0pt;\">68</span></p>"
        },
        {
          "id": 99063,
          "text": "<p><span style=\"font-size:11.0pt;\">35</span></p>"
        },
        {
          "id": 99064,
          "text": "<p><span style=\"font-size:11.0pt;\">43</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient with chronic kidney disease has the following laboratory reports. Calculate the anion gap in this patient. Na<sup>+</sup>: 145 mEq/L, K<sup>+</sup> 4 mEq/L Cl: 90 mEq/L HCO3: 20 mEq/L. (INICET MAY 2023)</span></p>",
      "unique_key": "Q9165858",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506525,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C)&nbsp;35</strong></span></p><p><br><span style=\"font-size:12pt;\">The anion gap is calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anion&nbsp;Gap = Na−(Cl+HCO3)</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Anion&nbsp;Gap=145−(90+20)=35</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The anion gap is calculated as Na - (Cl + HCO3), and a high anion gap may indicate metabolic acidosis.</span></p>",
      "correct_choice_id": 99063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9919,
      "choices": [
        {
          "id": 39642,
          "text": "<p><span style=\"font-size:12pt;\">Adult-onset Still's disease</span></p>"
        },
        {
          "id": 39643,
          "text": "<p><span style=\"font-size:12pt;\">Pachyonychia congenita</span></p>"
        },
        {
          "id": 39644,
          "text": "<p><span style=\"font-size:12pt;\">Psoriasis</span></p>"
        },
        {
          "id": 39645,
          "text": "<p><span style=\"font-size:12pt;\">Lichen planus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Based on the patient's history of relapsing, remitting, mildly itchy erythematous plaques on the scalp, sacral area, and knees, along with joint pain and the displayed nail changes in the image below, what would be your diagnosis?</span>(INICET MAY 2022)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/untitled-13529.jpg\" alt=\"\" width=\"300\" height=\"200\"></p>",
      "unique_key": "Q7505220",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506506,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Psoriasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The diagnosis in this patient showing <strong>nail pitting, oil drop sign, and salmon patches</strong> in fingernails is psoriasis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The nail changes shown in the image, such as <strong>nail pitting</strong> and <strong>onycholysis (separation</strong> of the nail from the nail bed), along with the <strong>patient's history</strong> of itchy <strong>erythematous plaques</strong> and <strong>joint pain,</strong> are characteristic of psoriasis.</span></li><li><span style=\"font-size:12pt;\">Psoriasis can affect the <strong>skin and joints</strong>, leading to <strong>psoriatic arthritis.</strong></span></li><li><span style=\"font-size:12pt;\">About <strong>5-30%</strong> of patients with <strong>cutaneous</strong> psoriasis have <strong>psoriatic arthritis (PsA)</strong>.</span></li><li><span style=\"font-size:12pt;\">At any given time, <strong>40%</strong> of psoriasis cases have changes to their <strong>nails</strong>.</span></li><li><span style=\"font-size:12pt;\">Nail psoriasis is linked to more <strong>severe psoriasis</strong>, <strong>longer disease duration</strong>, <strong>psoriatic arthritis</strong>, and <strong>family</strong> history of the condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Nail changes in psoriasis:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-21-191308.png\" alt=\"\" width=\"1000\" height=\"347\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Salmon patches&nbsp;</strong>or <strong>subungual oil drop sign</strong> is extremely specific <strong>pathognomonic</strong> sign of nail psoriasis. It looks like an <strong>oil</strong> droplet and is a <strong>yellowish</strong>, <strong>reddish</strong> discoloration in the nail bed.</span></li><li><span style=\"font-size:12pt;\">However, the most frequent symptom is nail <strong>pitting</strong>.</span></li><li><span style=\"font-size:12pt;\">Individual pits are <strong>irregular</strong> in shape and uniform in <strong>depth</strong>. These nail pits, also referred to as <strong>Thimble</strong> <strong>pits</strong>, are brought on by the <strong>proximal</strong> <strong>nail</strong> <strong>matrix's</strong> involvement.</span></li><li><span style=\"font-size:12pt;\"><strong>Subungual</strong>&nbsp;<strong>hyperkeratosis</strong>, <strong>splinter</strong> <strong>hemorrhages</strong>, and <strong>distal</strong> <strong>onycholysis</strong> are additional symptoms of nail bed disease.</span></li><li><span style=\"font-size:12pt;\">There might also be <strong>leukonychia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture4033.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Pitting affecting the fingernails</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture41.jpg\" alt=\"\" width=\"300\" height=\"205\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Onycholysis along with pitting and salmon patches in fingernails</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture42.jpg\" alt=\"\" width=\"300\" height=\"213\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Leukonychia in a patient with psoriasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture43.jpg\" alt=\"\" width=\"300\" height=\"364\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Nail plate thickening and crumbling resulting in complete nail dystrophy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Adult-onset Still's disease</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This <strong>systemic inflammatory</strong> condition typically presents with a <strong>salmon</strong>-<strong>pink</strong> rash, <strong>fever</strong>, and <strong>arthritis</strong> but is not typically associated with the nail changes seen in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Pachyonychia congenita</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A rare genetic condition affecting the nails, characterized by <strong>thickened nails (pachyonychia</strong>) as seen in the image below<strong>.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture44.jpg\" alt=\"\" width=\"300\" height=\"226\"></strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Lichen planus</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This condition can affect the nails, causing <strong>thinning</strong> and <strong>splitting</strong>, and it can also lead to <strong>lacy</strong> <strong>white</strong> lesions on the <strong>mucous</strong> membranes (<strong>Wickham's</strong> <strong>striae</strong>), but the nail changes in the image are more characteristic of psoriasis, and <strong>lichen</strong> <strong>planus</strong> <strong>doesn’t</strong> commonly <strong>cause</strong> <strong>joint</strong> <strong>pain</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When presented with <strong>nail pitting, onycholysis, erythematous plaques</strong> with scales on common sites such as the <strong>scalp, sacral area, and knees</strong>, along with <strong>joint</strong> <strong>pain</strong>, consider <strong>psoriasis</strong> as a likely diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 35 page no 35.4-35.6</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison’s principles of internal medicine 20<sup>th</sup> edition Page no 333</strong></span></p>",
      "correct_choice_id": 39644,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5835,
      "choices": [
        {
          "id": 23310,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue pregnancy</span></span></span></p>"
        },
        {
          "id": 23311,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terminate pregnancy</span></span></span></p>"
        },
        {
          "id": 23312,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre- invasive diagnostic test</span></span></span></p>"
        },
        {
          "id": 23313,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosome screening</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old pregnant woman at 13 weeks of gestation informs you about accidental exposure to radiation from a chest X-ray at 7 weeks of gestation. What should be the next step advised to her?</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (NEET PG 2020)</span></span></span></p>",
      "unique_key": "Q3199676",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506498,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Continue pregnancy </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The risks for malformations, growth restriction, or abortion are not increased from a radiation dose of less than 0.05 Gy (5 rads).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since diagnostic X-rays seldom exceed 0.1 Gy (10 rads), the risk is negligible. A 0.1 Gy exposure is equivalent to more than 1000 chest X-rays.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hence, continuing pregnancy is the most appropriate advice to this woman.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Terminate pregnancy:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Termination is not necessary as the radiation dose from a single chest X-ray is significantly lower than the threshold for increased risks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pre-invasive diagnostic test:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is not required in this scenario as the radiation dose is too low to justify invasive diagnostics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chromosome</strong> <strong>screening</strong>: Chromosome screening is unnecessary because the radiation dose from a chest X-ray does not significantly increase the risk of chromosomal abnormalities.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The risk for fetal malformations, growth restriction, or abortion is not increased from a radiation dose of less than 0.05 Gy (5 rads).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 2265, Williams Obstetrics, 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23310,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10877,
      "choices": [
        {
          "id": 43474,
          "text": "<p><span style=\"font-size:12.0pt;\">12-16 weeks</span></p>"
        },
        {
          "id": 43475,
          "text": "<p><span style=\"font-size:12.0pt;\">20-24 weeks</span></p>"
        },
        {
          "id": 43476,
          "text": "<p><span style=\"font-size:12.0pt;\">6-8 weeks</span></p>"
        },
        {
          "id": 43477,
          "text": "<p><span style=\"font-size:12.0pt;\">3-4 weeks</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 38-year-old man comes for a follow-up visit after a vasectomy. How long should he and his partner continue using a barrier method of contraception after the procedure? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q6863977",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506503,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. 12-16 Weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Following Vasectomy, the use of barrier methods of contraception are recommended for 3 months or 12 weeks, as even though it is a permanent method, the spermatozoa takes up to three months to clear out from the tract/ ejaculatory ducts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Post-vasectomy, it is recommended to continue using a barrier contraceptive method for 12-16 weeks to ensure that all remaining sperm have been cleared from the ejaculatory ducts.</span></p>",
      "correct_choice_id": 43474,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10413,
      "choices": [
        {
          "id": 41618,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 41619,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 41620,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 41621,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child is brought to the casualty with a history of choking. On examination, there is decreased air entry in the left lung. What would be the correct management?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Bronchoscopy</span></li><li><span style=\"font-size:12.0pt;\">Computed tomography scan</span></li><li><span style=\"font-size:12.0pt;\">ICD insertion</span></li><li><span style=\"font-size:12.0pt;\">Chest x-ray</span></li></ol>",
      "unique_key": "Q6469015",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506504,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A child presenting with a history of choking and decreased air entry in the left lung is highly suggestive of a <strong>foreign body lodged in the left bronchus</strong>. The correct management steps include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Bronchoscopy:&nbsp;</strong>This is the gold standard for both the diagnosis and removal of the foreign body. Rigid bronchoscopy is typically performed by a specialist, such as an otolaryngologist or pulmonologist, to visualize and extract the foreign body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Chest X-ray:&nbsp;</strong>This is an essential initial investigation to assess for the presence of a foreign body. Although many foreign bodies are radiolucent, secondary findings such as air trapping, obstructive emphysema, atelectasis, asymmetric hyperinflation, mediastinal shift, and consolidation can be indicative of foreign body aspiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. CT scan:&nbsp;</strong>While a CT scan has high sensitivity and specificity for detecting radiolucent foreign bodies, it is not routinely performed in this situation due to the high radiation exposure, especially in children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. ICD insertion:&nbsp;</strong>Insertion of an intercostal drain (ICD) is not indicated unless there is clinical evidence of pneumothorax or other complications that require it. A chest X-ray is essential before deciding on this intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Approach:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A detailed history and physical examination are critical when a child presents with choking.</span></li><li><span style=\"font-size:12.0pt;\">A chest X-ray should be performed to assess for secondary signs of foreign body aspiration.</span></li><li><span style=\"font-size:12.0pt;\">Bronchoscopy should be conducted even if imaging is negative but clinical suspicion remains high.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a child with suspected foreign body aspiration, a chest X-ray and bronchoscopy are the key steps for diagnosis and management. Bronchoscopy allows for both visualization and removal of the foreign body.</span></p>",
      "correct_choice_id": 41621,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13904,
      "choices": [
        {
          "id": 55577,
          "text": "<p><span style=\"font-size:12.0pt;\">C4</span></p>"
        },
        {
          "id": 55578,
          "text": "<p><span style=\"font-size:12.0pt;\">C5</span></p>"
        },
        {
          "id": 55579,
          "text": "<p><span style=\"font-size:12.0pt;\">C6</span></p>"
        },
        {
          "id": 55580,
          "text": "<p><span style=\"font-size:12.0pt;\">C7</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient is unable to abduct his arm. Which of the following root values is likely to be affected? (</span>INICET Nov 2020)</p>",
      "unique_key": "Q3861989",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506533,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. C5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most likely cause of the inability to abduct the arm is a C5 root lesion.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">The C5 spinal nerve plays a crucial role in controlling shoulder abduction. It gives rise to the axillary nerve, which innervates the deltoid muscle. Damage or compression of the C5 nerve root or axillary nerve can result in weakness or paralysis of the deltoid muscle, leading to difficulty in abducting the arm.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Deltoid is supplied by axillary nerve which has the root value of C4-C6. The C5 component is responsible for abduction.Other components help in flexion and extensionm at shoulder joint</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option A.&nbsp;C4:</strong> The C4 spinal nerve does not directly innervate the muscles responsible for shoulder abduction. It primarily supplies sensory information to areas of the neck and upper shoulders.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option C</strong>. <strong>C6:</strong> The C6 spinal nerve primarily innervates the muscles responsible for elbow flexion and wrist extension, not shoulder abduction. Damage to the C6 nerve root would affect these functions rather than shoulder abduction.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option D</strong>. <strong>C7: </strong>The C7 spinal nerve primarily innervates the muscles responsible for elbow and wrist flexion and finger extension. It is not directly involved in shoulder abduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Muscles of the shoulder</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-171540.jpg\" alt=\"\" width=\"1000\" height=\"1022\"></p>",
      "correct_choice_id": 55578,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14632,
      "choices": [
        {
          "id": 58489,
          "text": "<p><span style=\"font-size:12.0pt;\">FESS (functional endoscopic sinus surgery)</span></p>"
        },
        {
          "id": 58490,
          "text": "<p><span style=\"font-size:12.0pt;\">Needle aspiration</span></p>"
        },
        {
          "id": 58491,
          "text": "<p><span style=\"font-size:12.0pt;\">CT angiogram</span></p>"
        },
        {
          "id": 58492,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous antibiotics for 7 days</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents with a tender pulsatile mass as shown in the image below. What is the next step?&nbsp;</span>(NEET PG 2022)</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:11.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/07/ns27.jpg\" alt=\"\" width=\"300\" height=\"343\"></span></p>",
      "unique_key": "Q4878429",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506526,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) CT angiogram</strong></span></p><ul><li><span style=\"font-size:12pt;\">Cirsoid aneurysm is a rare type of vascular malformation that involves the dilation of multiple blood vessels and their adjacent tissue, resulting in a tangled mass of blood vessels resembling a \"bag of worms\".</span></li><li><span style=\"font-size:12pt;\">These aneurysms are most commonly found in the scalp, face, and neck regions, but can occur in other parts of the body as well.</span></li><li><span style=\"font-size:12pt;\">Symptoms may include visible swelling, throbbing or pulsating sensation, pain, and potential for bleeding or rupture.</span></li><li><span style=\"font-size:12pt;\">Diagnosis of cirsoid aneurysm is typically made through imaging tests such as USG Doppler, CT, MRI, or angiography.</span></li><li><span style=\"font-size:12pt;\">If the pulsatile mass is suspected to be a vascular lesion or aneurysm, a CT angiogram would be a suitable choice as it provides detailed visualization of the blood vessels, and can help define the anatomy and blood supply of the lesion.</span></li><li><span style=\"font-size:12pt;\">It aids in planning therapeutic interventions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. FESS (functional endoscopic sinus surgery):&nbsp;</strong>FESS is a procedure used to treat chronic sinusitis and nasal polyps. It involves using an endoscope to view and remove the sinus blockages. This procedure is not relevant to the diagnosis or management of a vascular malformation like cirsoid aneurysm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Needle aspiration:&nbsp;</strong>Needle aspiration is contraindicated in this scenario due to the risk of bleeding. Attempting to aspirate a pulsatile vascular lesion can lead to significant hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Intravenous antibiotics for 7 days:&nbsp;</strong>Intravenous antibiotics are typically used to treat infections. While pain and tenderness might suggest an infectious process, the presence of a pulsatile mass strongly suggests a vascular etiology, making antibiotics inappropriate as a primary intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A CT angiogram is crucial for diagnosing and planning the treatment of a cirsoid aneurysm due to its detailed visualization of blood vessels.</span></li><li><span style=\"font-size:12pt;\">Needle aspiration is contraindicated due to the risk of bleeding.</span></li></ul>",
      "correct_choice_id": 58491,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11245,
      "choices": [
        {
          "id": 44946,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammatory condition</span></span></p>"
        },
        {
          "id": 44947,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Descending paralysis is seen</span></span></p>"
        },
        {
          "id": 44948,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasmapheresis is a treatment method</span></span></p>"
        },
        {
          "id": 44949,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Demyelinating disorder</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true about Typical Guillain-Barre syndrome except: (NEET PG 2019)</span></span></p>",
      "unique_key": "Q8290426",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506528,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Descending paralysis is seen</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guillain-Barre Syndrome (GBS) is typically characterized by ascending paralysis, starting from the lower extremities and moving upward, not descending paralysis. This pattern begins with weakness in the legs that spreads to the upper limbs and the face, associated with the demyelination of peripheral nerves. The condition is indeed inflammatory and primarily affects the peripheral nervous system, leading to demyelination and sometimes axonal damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Inflammatory condition:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, GBS is an acute inflammatory demyelinating polyneuropathy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Plasmapheresis is a treatment method:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, plasmapheresis is used to remove antibodies from the blood that are thought to be involved in the immune attack on the peripheral nerves.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Demyelinating disorder:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, GBS involves the demyelination of peripheral nerves, leading to muscle weakness and paralysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GBS produces neuro-radiculopathy due to demyelination causing ascending paralysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes of Descending paralysis (<strong>Mnemonic: Bipolar disorder [BPD]</strong>):</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B: B</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">otulism</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P: P</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">orphyria, Polio</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D: D</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">iphtheria</span></span></span></span></p>",
      "correct_choice_id": 44947,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49027,
      "choices": [
        {
          "id": 195683,
          "text": "<p><span style=\"font-size:18px;\">UPT before DMPA</span></p>"
        },
        {
          "id": 195684,
          "text": "<p><span style=\"font-size:18px;\">Give DMPA</span></p>"
        },
        {
          "id": 195685,
          "text": "<p><span style=\"font-size:18px;\">Give DMPA with 7 days of barrier</span></p>"
        },
        {
          "id": 195686,
          "text": "<p><span style=\"font-size:18px;\">Wait till next period</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A 32-year-old woman with no significant medical history, who has been using depot medroxyprogesterone acetate (DMPA) for contraception, presents to the clinic after missing her scheduled injection by 14 days. She denies any sexual activity since her last injection. Her last menstrual period was 10 weeks ago, and she has no signs of pregnancy. What is the most appropriate recommendation for this patient regarding contraception? </strong><i><strong>[INICET NOV 2023]&nbsp;</strong></i></span></p>",
      "unique_key": "Q5575001",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506497,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Give DMPA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">As per the ministry of health and family welfare guidelines, ideally Inj DMPA (Antara) should be administered 3 monthly as shown in the table below:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Follow up of clients (coming on scheduled date for next injection i.e after 3 months</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/1_UFQNIHz.png\" width=\"1024\" height=\"205\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Defaulter:&nbsp;A defaulter is a client who does not return for the next injection on the scheduled date; but comes for it within the grace period&nbsp;i.e. 2 weeks earlier and upto 4 weeks later from the scheduled date).</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/2_LOTjz82.png\" width=\"1023\" height=\"370\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Drop out:&nbsp;A&nbsp;dropout is a MPAclient who comes for the next injection after the grace period of 4 weeks is over and more than 4 months have passed since she took her last injection</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/3_nN8y3tH.png\" width=\"1023\" height=\"207\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">In the scenario mentioned above, the patient is a DEFAULTER and hence the Inj should be administered as she falls within the grace period</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. UPT before DMPA</strong>: This would be appropriate if the patient&nbsp;was a drop-out, i.e. if she had presented &gt; 4 weeks of the date that she had to come on.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Give DMPA with 7 days of barrier</strong>: This approach would be recommended if the injection was delayed beyond&nbsp;4 weeks.&nbsp;</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Option D. Wait till next period</strong>: This unnecessarily delays contraceptive protection and is not recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">When a patient misses her scheduled DMPA injection by up to&nbsp;30 days, the most appropriate recommendation is to administer DMPA directly without pregnancy testing.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">This is because Inj DMPA is known to cause a delayed return to fertlity.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">This ensures continuous contraceptive protection while following evidence-based guidelines that balance safety with practical clinical considerations.</span></p></li></ul>",
      "correct_choice_id": 195684,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21770,
      "choices": [
        {
          "id": 87044,
          "text": "<p><span style=\"font-size:12pt;\">Serum uric acid levels</span></p>"
        },
        {
          "id": 87045,
          "text": "<p><span style=\"font-size:12pt;\">Liver Function tests</span></p>"
        },
        {
          "id": 87046,
          "text": "<p><span style=\"font-size:12pt;\">Complete blood count</span></p>"
        },
        {
          "id": 87047,
          "text": "<p><span style=\"font-size:12pt;\">Urine dipstick</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A nulliparous woman presented with 26 weeks of gestation for routine antenatal check-up. Her blood pressure was 150/90 mmHg. What can be the next best step?&nbsp;</span>(FMGE JANUARY 2023)</p>",
      "unique_key": "Q4106847",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506518,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Urine dipstick</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A pregnant woman with BP &gt; 140/90 mmHg after 20 weeks of gestation should be evaluated for gestational hypertension or Pre-eclampsia.</span></li><li><span style=\"font-size:12pt;\">So, the next step should be looking out for proteinuria by Urine dipstick test.&nbsp; (Here Proteinuria refers to urine dipstick greater than or equal to +2 (1 gm/L) on at least two random clean catch samples &nbsp;&nbsp;or a &nbsp;total 24 hour urine protein &gt; 0.3 gm)</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/28/screenshot-2023-09-28-191550.jpg\" alt=\"\" width=\"1000\" height=\"422\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Serum Uric Acid</strong>: Blood changes in pre-eclampsia may not be very specific however a serum Uric acid of more than 4.5 mg/dl may be considered as a biochemical marker</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Liver Function tests&nbsp;</strong>and<strong> Option C. Complete blood count</strong>: LFTs may be raised and there may altered coagulation profile and thrombocytopenia</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In pregnant women with BP &gt; 140/90 mmHg after 20 weeks of gestation, the next best step is to evaluate for proteinuria using a urine dipstick test to screen for pre-eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of Obstetrics page 256, 262</strong></span></p>",
      "correct_choice_id": 87047,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31085,
      "choices": [
        {
          "id": 124218,
          "text": "<p><span style=\"font-size:12.0pt;\">Galactokinase</span></p>"
        },
        {
          "id": 124219,
          "text": "<p><span style=\"font-size:12.0pt;\">Galactose-1-P Uridyl Transferase</span></p>"
        },
        {
          "id": 124220,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactose</span></p>"
        },
        {
          "id": 124221,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldolase B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A neonate on breast feeding develops jaundice. Urine Benedict’s test is positive. The enzyme deficiency is_________: (FMGE JULY 2023)</span></p>",
      "unique_key": "Q5885618",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506524,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Galactose-1-P Uridyl Transferase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the enzyme deficient in classic galactosemia, a condition where galactose accumulates in the blood. This occurs because the neonate's diet (breast milk or formula) contains lactose, which is broken down into glucose and galactose. The inability to further metabolize galactose leads to its accumulation, causing symptoms like jaundice, hepatomegaly, and a positive Benedict's test (due to the presence of reducing sugars like galactose in the urine).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Galactokinase:</strong> While a deficiency in galactokinase can cause galactosemia, the clinical presentation is typically milder compared to galactose-1-phosphate uridyltransferase deficiency. Galactokinase deficiency usually leads to cataract formation due to the accumulation of galactitol in the lens of the eye, but it doesn't typically cause severe jaundice or a positive Benedict's test, which indicates the presence of reducing sugars (like galactose) in urine.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-180345.png\" alt=\"\" width=\"500\" height=\"406\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lactose:</strong> Lactose is a disaccharide composed of glucose and galactose, not an enzyme. Deficiency of lactase, the enzyme that breaks down lactose, leads to lactose intolerance, which typically presents with gastrointestinal symptoms like bloating, diarrhea, and gas, but not jaundice or a positive Benedict's test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aldolase B:</strong> Aldolase B deficiency leads to hereditary fructose intolerance. When fructose (from fruits, sweeteners, and some infant formulas) is ingested, it cannot be properly metabolized, leading to hypoglycemia and other symptoms. This condition does not lead to the accumulation of galactose, hence not causing the symptoms seen in this neonate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The neonate's symptoms, including jaundice and a positive Benedict's test for reducing sugars in the urine, are indicative of galactosemia. In galactosemia, there is a deficiency of the enzyme galactose-1-phosphate uridyl transferase, which is involved in the conversion of galactose-1-phosphate to glucose-1-phosphate. Gal-1-P accumulates causes product inhibition of galactokinase resulting in galactose accumulation which comes out in urine giving positive Benedict’s test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Harper’s Illustrated Biochemistry 32nd edition Page no. 198</strong></span></p>",
      "correct_choice_id": 124219,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20265,
      "choices": [
        {
          "id": 81021,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal cell carcinoma</span></p>"
        },
        {
          "id": 81022,
          "text": "<p><span style=\"font-size:12.0pt;\">Kaposi sarcoma</span></p>"
        },
        {
          "id": 81023,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant melanoma</span></p>"
        },
        {
          "id": 81024,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old HIV patient presented with a painful lesion, as shown in the image. What is the most likely diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170516.jpg\" alt=\"\" width=\"300\" height=\"303\"></span></p>",
      "unique_key": "Q6522920",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506514,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Kaposi sarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma (KS) is a common malignancy in patients with HIV/AIDS. It is caused by human herpesvirus 8 (HHV-8) and typically presents as painless or painful, violaceous (purple) lesions on the skin and mucous membranes, including the oral cavity. The image shows such a lesion on the palate, which is characteristic of Kaposi sarcoma. These lesions are vascular in nature and can vary in color from red to purple, often with a raised or nodular appearance. In HIV patients, Kaposi sarcoma is an AIDS-defining condition and is often seen in those with significant immunosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Basal cell carcinoma:</strong> This type of skin cancer usually occurs in sun-exposed areas of the skin and rarely affects mucous membranes. It typically presents as a pearly or waxy bump, not as multiple purple lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Malignant melanoma:</strong> While melanomas can appear as pigmented lesions, they are usually black or brown and rarely present as multiple violaceous lesions in the oral cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Squamous cell carcinoma:</strong> This type of cancer can occur in the oral cavity but usually presents as a non-healing ulcer or a raised, firm, scaly plaque. It does not have the characteristic color and appearance of Kaposi sarcoma lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma should be suspected in HIV patients presenting with violaceous lesions on the skin or mucous membranes. It is an AIDS-defining condition associated with HHV-8 infection.</span></p>",
      "correct_choice_id": 81022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11364,
      "choices": [
        {
          "id": 45422,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        },
        {
          "id": 45423,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 45424,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        },
        {
          "id": 45425,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A male patient presents to the emergency department. The arterial blood gas report is as follows: pH 7.2, pCO2 81mm Hg, and HCO3 40 mEq/L. Which of the following is the most likely diagnosis? (Neet pg 2022)</span></p>",
      "unique_key": "Q3764416",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506535,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C. Respiratory acidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The arterial blood gas (ABG) report shows a pH of 7.2, which indicates acidosis (normal pH: 7.35-7.45). The partial pressure of carbon dioxide (pCO2) is elevated at 81 mm Hg (normal range: 35-45 mm Hg), indicating that the acidosis is due to a respiratory cause, as CO2 retention leads to respiratory acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The bicarbonate (HCO3) level is elevated at 40 mEq/L (normal range: 22-28 mEq/L). This elevation suggests that the kidneys are compensating for the respiratory acidosis by retaining bicarbonate to buffer the excess hydrogen ions, indicating a chronic component to the respiratory acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In summary, the primary disturbance is respiratory acidosis, evidenced by the elevated pCO2, and the elevated bicarbonate suggests a compensatory response by the kidneys, characteristic of chronic respiratory acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Respiratory alkalosis</strong>: Respiratory alkalosis is characterized by a high pH and low pCO2, which is the opposite of the findings in this ABG report.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Metabolic acidosis: </strong>Metabolic acidosis would present with a low pH and a low bicarbonate level. However, in this case, the bicarbonate is elevated, not decreased, indicating the primary issue is not metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Metabolic alkalosis: </strong>Metabolic alkalosis is characterized by a high pH and elevated bicarbonate, but without the accompanying high pCO2. The presence of high pCO2 and low pH indicates the primary disturbance is respiratory, not metabolic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A blood gas report showing low pH and high pCO2 with compensatory elevated bicarbonate indicates respiratory acidosis, often with a chronic component if the bicarbonate is significantly elevated.</span></p>",
      "correct_choice_id": 45424,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6983,
      "choices": [
        {
          "id": 27900,
          "text": "<p><span style=\"font-size:12.0pt;\">Influx of Na<sup>+</sup></span></p>"
        },
        {
          "id": 27901,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Efflux of Na<sup>+</sup></span></p>"
        },
        {
          "id": 27902,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Influx of K<sup>+</sup></span></p>"
        },
        {
          "id": 27903,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Efflux of K<sup>+</sup></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The image shows changes in membrane potential during an action potential. The region marked between 4 to 5 is due to?</span>(INICET NOV 2022)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/untitled-982_1Mke7Lg.jpg\" alt=\"\" width=\"500\" height=\"316\"></p>",
      "unique_key": "Q6035357",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506501,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Efflux of K<sup>+</sup></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The action potential curve shows the different phases of an action potential in a neuron. The region marked between 4 and 5 corresponds to repolarization and hyperpolarization.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Phase 4 to 5 (Repolarization and Hyperpolarization):</strong> During this phase, voltage-gated potassium channels remain open, and there is an efflux of K+ ions from the cell, causing the membrane potential to return to the resting level or even become more negative (hyperpolarization).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Influx of Na+</strong>: This occurs during the depolarization phase (Phase 0 to 1), not during repolarization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Efflux of Na+</strong>: This does not occur in the action potential phases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Influx of K+</strong>: Potassium ions typically move out of the cell (efflux) during repolarization, not into the cell.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/untitled-983.jpg\" alt=\"\" width=\"700\" height=\"585\"></p>",
      "correct_choice_id": 27903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57003,
      "choices": [
        {
          "id": 227401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fothergill</span></span></span></p>"
        },
        {
          "id": 227402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">McCall Culdoplasty</span></span></span></p>"
        },
        {
          "id": 227403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Le fort</span></span></span></p>"
        },
        {
          "id": 227404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Shirodkar sling</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 30-year-old P2L2 woman presents with cervical elongation. Her family is complete. What is the preferred surgery advised?</span><span style=\"font-size:12.0pt\"> (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q1747426",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506529,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Fothergill</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Fothergill procedure, also known as the Manchester repair, is the preferred surgical treatment for women with cervical elongation who have completed their families and do not wish to have more children. This procedure involves cervical amputation and reinforcement of the pelvic ligaments, providing adequate support without removing the uterus. It is suitable for younger women who are not candidates for a hysterectomy but have significant cervical elongation contributing to prolapse symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. McCall Culdoplasty:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This procedure is typically <strong>performed to correct vaginal vault prolapse during or after hysterectomy</strong> and is not specifically indicated for cervical elongation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Le fort:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This procedure involves partial closure of the vagina and is generally recommended for <strong>elderly, non-sexually active women</strong> who are not candidates for more invasive surgeries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Shirodkar sling:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This procedure is used for pelvic organ prolapse in <strong>young, nulliparous</strong> women or women who wish to preserve fertility by anchoring the uterus, usually to the sacral promontory. It is not indicated for women with completed families and cervical elongation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prolapse management by age group: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121840.jpg\" style=\"height:625px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 227401,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5939,
      "choices": [
        {
          "id": 23726,
          "text": "<p><span style=\"font-size:12.0pt;\">Copper T</span></p>"
        },
        {
          "id": 23727,
          "text": "<p><span style=\"font-size:12.0pt;\">Implanon</span></p>"
        },
        {
          "id": 23728,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparoscopic tubal ligation</span></p>"
        },
        {
          "id": 23729,
          "text": "<p><span style=\"font-size:12.0pt;\">SC DMPA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a long-acting reversible contraceptive method?&nbsp;</span>(INICET MAY 2021)</p>",
      "unique_key": "Q1244543",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506519,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Laparoscopic tubal ligation</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Laparoscopic tubal ligation</strong> is a permanent form of contraception and is not classified as a long-acting reversible contraceptive (LARC). It involves the surgical closure or blocking of the fallopian tubes to prevent pregnancy permanently.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Long-acting reversible contraceptive (LARC) methods</strong> are effective for extended periods and can be reversed if desired. They include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Copper T:</strong> Correct. Copper T is an intrauterine device (IUD) that can provide contraception for several years.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Implanon:</strong> Correct. Implanon is a type of contraceptive implant that provides effective contraception for several years.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. SC DMPA:&nbsp;</strong>This is a LARC. It is a sub cutaneous preparation of depot medroxy progesterone acetate and is administered once in 3 months</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Laparoscopic tubal ligation is a permanent method of contraception and is not a long-acting reversible contraceptive (LARC).</span></p>",
      "correct_choice_id": 23728,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24702,
      "choices": [
        {
          "id": 98769,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 98770,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
        },
        {
          "id": 98771,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 98772,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 73-year-old individual arrives with painless rectal bleeding. Which of the listed investigations are conducted for this patient? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Colonoscopy</span></li><li><span style=\"font-size:12.0pt;\">CECT</span></li><li><span style=\"font-size:12.0pt;\">CEA</span></li><li><span style=\"font-size:12.0pt;\">CA 19-9</span></li></ol>",
      "unique_key": "Q7825123",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506515,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Colonoscopy:</strong> This is an endoscopic examination of the large bowel and the distal part of the small bowel. It provides a visual diagnosis and can offer biopsy or removal of suspected lesions. It is an essential diagnostic tool for any patient with per-rectal bleeding to identify potential sources such as polyps, tumors, or colitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. CECT (Contrast-Enhanced Computed</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Tomography)</strong>: &nbsp;CECT can provide detailed cross-sectional images of the body. In the context of rectal bleeding, it might be used to evaluate the extent of a detected tumor, check for metastatic disease, or to view vascular anomalies that might be causing the bleeding, such as arteriovenous malformations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. CEA (Carcinoembryonic Antigen)</strong>: CEA is a tumor marker. Its level can be elevated in colorectal cancers as well as other malignancies and conditions. Monitoring the levels of CEA might help in diagnosing, prognosis, and checking the recurrence of colorectal cancers.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. CA 19-9</strong>: CA 19-9 is another tumor marker. It is more typically associated with pancreatic cancer. However, its specificity for colorectal cancer is not as high as CEA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the patient's presenting symptom of painless rectal bleeding:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Colonoscopy is a primary diagnostic tool to visualize and biopsy any potential sources of bleeding.</span></li><li><span style=\"font-size:12.0pt;\">CECT could be useful in determining the extent of a potential tumor or to check for other causes of bleeding.</span></li><li><span style=\"font-size:12.0pt;\">CEA might be used to check for the possibility of colorectal cancer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence, the investigations that would be most appropriate and relevant for this patient would be options <strong>1, 2, and 3</strong>. Therefore, answer choice D) 1, 2, and 3 is correct.</span></p>",
      "correct_choice_id": 98772,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6532,
      "choices": [
        {
          "id": 26097,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits the release of acetylcholine</span></p>"
        },
        {
          "id": 26098,
          "text": "<p><span style=\"font-size:12.0pt;\">Release of noradrenaline at synaptic cleft</span></p>"
        },
        {
          "id": 26099,
          "text": "<p><span style=\"font-size:12.0pt;\">Selectively and irreversibly inhibits nicotinic receptors</span></p>"
        },
        {
          "id": 26100,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates muscarinic and nicotinic receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly woman received a Botox injection for the treatment of wrinkles.&nbsp; Which of the following is the mechanism of action of botulinum toxin?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q6232382",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506523,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Inhibits the release of acetylcholine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The botulinum toxin works by preventing acetylcholine from entering the synaptic cleft. Acetylcholine is exocytosed by SNARE protein, which is broken down by botulinum toxin. Consequently, it prevents acetylcholine from being released.</span></li><li><span style=\"font-size:12.0pt;\">Other agents that regulate the level of Ach in the synapse are:</span><ul><li><span style=\"font-size:12.0pt;\">Hemicholinium acts by inhibiting choline uptake (the rate limiting step in the synthesis of acetylcholine)</span></li><li><span style=\"font-size:12.0pt;\">Vesamicol inhibits the uptake of Acetylcholine into the vesicles.</span></li><li><span style=\"font-size:12.0pt;\">Physostigmine inhibits the breakdown of Ach at the synaptic cleft by the action of Acetylcholine esterase.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Release of noradrenaline at synaptic cleft:&nbsp;</strong>Botulinum toxin does not facilitate the release of noradrenaline. Its primary action is on the cholinergic neurons where it inhibits the release of acetylcholine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Selectively and irreversibly inhibits nicotinic receptors:&nbsp;</strong>Botulinum toxin does not directly inhibit nicotinic receptors. Instead, it prevents the release of acetylcholine, which means there is no neurotransmitter available to bind to and activate the nicotinic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Stimulates muscarinic and nicotinic receptors:&nbsp;</strong>Botulinum toxin does not stimulate muscarinic or nicotinic receptors. In fact, it decreases neurotransmission by preventing the release of acetylcholine, which would otherwise stimulate these receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Botulinum toxin inhibits the release of acetylcholine by cleaving SNARE proteins, thereby preventing neurotransmission at the neuromuscular junction and leading to muscle relaxation.</span></p>",
      "correct_choice_id": 26097,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54757,
      "choices": [
        {
          "id": 218493,
          "text": "<p><span style=\"font-size:18px;\">Hemophilus influenzae B</span></p>"
        },
        {
          "id": 218494,
          "text": "<p><span style=\"font-size:18px;\">Pneumococcal vaccine</span></p>"
        },
        {
          "id": 218495,
          "text": "<p><span style=\"font-size:18px;\">Hepatitis B</span></p>"
        },
        {
          "id": 218496,
          "text": "<p><span style=\"font-size:18px;\">Meningococcal vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>All of the following are types of polysaccharide vaccines except:&nbsp;[</strong><i><strong>INICET MAY 2024]</strong></i></span></p>",
      "unique_key": "Q5501523",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506513,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Hepatitis B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Hepatitis B is not a polysaccharide vaccine. It is a recombinant type of subunit vaccine, which means it is made using genetic engineering techniques to produce the surface antigens of the Hepatitis B virus</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Polysaccharide vaccines are designed to elicit an immune response specifically against the polysaccharides found on the surface of certain bacterial capsules. These vaccines include:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Haemophilus influenzae B (Hib) vaccine</strong>: Targets the polysaccharides on the surface of Haemophilus influenzae type B.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Pneumococcal vaccine</strong>: Targets the polysaccharides on the surface of Streptococcus pneumoniae.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Meningococcal vaccine</strong>: Targets the polysaccharides on the surface of Neisseria meningitidis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">These vaccines may also be available as glycoconjugate vaccines, which are designed to improve immunogenicity, especially in younger populations. However, the vaccine for <strong>Salmonella Typhimurium</strong> (Typhim VI) is available only in a polysaccharide form.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Hepatitis B is a recombinant subunit vaccine, not a polysaccharide vaccine.</strong> Polysaccharide vaccines include those for pneumococcus, meningococcus, and Haemophilus influenzae type B.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Note</strong> - Polysaccharide vaccines work by stimulating the immune system to produce antibodies specifically against the polysaccharide components of the bacterial capsule. These polysaccharides are unique to particular strains or serotypes of bacteria, making the vaccine effective in targeting those specific types.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Limitations of Polysaccharide vaccines</strong>: serotype-specific and do not facilitate herd immunity due to their lack of a robust T-cell response.&nbsp;&nbsp;</span></p>",
      "correct_choice_id": 218495,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43964,
      "choices": [
        {
          "id": 175519,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 175520,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemochromatosis</span></p>"
        },
        {
          "id": 175521,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        },
        {
          "id": 175522,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Low transferrin saturation is seen in:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p>",
      "unique_key": "Q8018144",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506510,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Iron deficiency anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Low transferrin saturation is indicative of inadequate iron within the body to fully saturate transferrin, which is the main protein in the blood that binds to iron and transports it throughout the body. This condition is a hallmark of iron deficiency anemia, where there is a decreased level of total body iron.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Transferrin Saturation (%) = (Serum Iron / Total Iron-Binding Capacity) × 100</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Normal</strong>: ~20–45%</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low</strong>: Indicates not enough iron bound to transferrin</span></li><li><span style=\"font-size:12.0pt;\"><strong>High</strong>: Indicates excess circulating iron</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hemochromatosis:&nbsp;</strong>Incorrect because this is characterized by increased iron levels in the body, typically leading to high transferrin saturation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thalassemia</strong>: Incorrect because this is a genetic disorder that affects the production of hemoglobin, not primarily associated with iron deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Megaloblastic anemia</strong>: Incorrect as this anemia type is usually due to deficiencies in vitamin B12 or folate, not iron.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_V7GtPbF.png\" width=\"1184\" height=\"363\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Low transferrin saturation is a significant marker for diagnosing iron deficiency anemia, reflecting a shortfall in available iron for red blood cell production.</span></p>",
      "correct_choice_id": 175519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57448,
      "choices": [
        {
          "id": 229165,
          "text": "<p><span style=\"font-size:18px;\">Tesamorelin</span></p>"
        },
        {
          "id": 229166,
          "text": "<p><span style=\"font-size:18px;\">Sermorelin</span></p>"
        },
        {
          "id": 229167,
          "text": "<p><span style=\"font-size:18px;\">Somatropin</span></p>"
        },
        {
          "id": 229168,
          "text": "<p><span style=\"font-size:18px;\">Pegvisomant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Which of the following growth hormone analogue that is not used for treatment of GH deficiency but is used in the treatment of HIV-associated lipodystrophy? (NEET PG 2024)</span></p>",
      "unique_key": "Q6836576",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506499,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Tesamorelin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that is specifically used in the treatment of HIV-associated lipodystrophy, a condition characterized by abnormal distribution of body fat in patients with HIV. Tesamorelin reduces visceral adipose tissue and improves the body composition of individuals with this condition. Unlike other growth hormone analogues, Tesamorelin is not primarily used for treating growth hormone deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Sermorelin</strong>: Sermorelin is a synthetic analogue of GHRH used to diagnose and treat growth hormone deficiency. It is not indicated for the treatment of HIV-associated lipodystrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Somatropin</strong>: Somatropin is a recombinant form of human growth hormone used to treat growth hormone deficiencies. It is not used for the treatment of HIV-associated lipodystrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Pegvisomant</strong>: Pegvisomant is a growth hormone receptor antagonist used in the treatment of acromegaly. It is not used for HIV-associated lipodystrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Tesamorelin is a growth hormone-releasing hormone analogue used specifically for the treatment of HIV-associated lipodystrophy, distinguishing it from other growth hormone analogues that are used for treating growth hormone deficiencies.</span></p>",
      "correct_choice_id": 229165,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15604,
      "choices": [
        {
          "id": 62376,
          "text": "<p><span style=\"font-size:12.0pt;\">Distal 1/3rd</span></p>"
        },
        {
          "id": 62377,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle 1/3rd</span></p>"
        },
        {
          "id": 62378,
          "text": "<p><span style=\"font-size:12.0pt;\">Proximal 1/3rd</span></p>"
        },
        {
          "id": 62379,
          "text": "<p><span style=\"font-size:12.0pt;\">Scaphoid tubercle</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which part of scaphoid is most susceptible to avascular necrosis? (NEET PG &nbsp;2019)</span></p>",
      "unique_key": "Q4462669",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506521,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p style=\"margin-left:0cm;text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C) Proximal 1/3rd</strong></span></p><p style=\"margin-left:0cm;text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>SCAPHOID FRACTURE</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Salient features:&nbsp;</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">It is the <strong>most commonly fractured bone in the carpus</strong>, in adult as well as children.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Most commonly in males between the ages of 15 and 30.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fullness and tenderness in anatomical snuff box.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Proximal pressure along the axis of the thumb may be painful.</span></p></li></ul></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Most common location: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Adults and adolescents</strong>: Middle third (Waist) fractures (70%) &gt; proximal pole fracture (20%) &gt; distal pole fracture (10%).&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Children</strong>: Distal pole avulsion type fracture.</span></p></li></ul></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Pathogenesis of AVN:</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Most of the blood supply to the scaphoid enters distally, so blood supply of scaphoid diminishes proximally.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">This accounts for the fact that 1% of distal third, 20% of middle third, 40% of proximal third and 100% of proximal pole fractures result in avascular necrosis or non-union of the proximal fragment.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Thus, the proximal third of the scaphoid is most susceptible to avascular necrosis (AVN) due to its precarious retrograde blood supply.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fracture in the waist (middle third) can disrupt this blood flow to the proximal fragment, leading to AVN.</span></p></li></ul></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Diagnosis:&nbsp;</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A wrist sprain that is sufficiently severe to require radiographic examination initially should be treated as a possible fracture of the scaphoid, and radiographs should be repeated in 2 weeks even though initial radiographs may be negative.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Recent fracture shows only in the oblique view.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">MRI can diagnose occult fractures.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">MRI, especially with gadolinium enhancement, also is useful in assessing the vascularity of a fractured scaphoid.</span></p></li></ul></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Nondisplaced, Stable Scaphoid Fractures:&nbsp;</strong>Scaphoid Glass Holding Cast.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Displaced, Unstable Scaphoid Fractures:&nbsp;</strong>Headless Screw (Herbert) is used</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Complication:</strong> Non-union &gt; Avascular Necrosis</span></p></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Distal 1/3<sup>rd</sup></strong>. Distal 1/3<sup>rd</sup> portion of the scaphoid is a well vascularized area, so fracture to this part is often undisplaced or minimally displaced, thus they heal faster with conservative management. This portion of scaphoid is fractured in 10% of cases. AVN of this part occurs in 1% cases.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Middle 1/3<sup>rd</sup></strong>. Middle 1/3<sup>rd</sup> or the waist of scaphoid is most commonly fractures, accounting for 70% of cases. But the chances of AVN at this portion are around 20%.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Scaphoid tubercle</strong>. Avulsion fracture of scaphoid tubercle are rare.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">The proximal 1/3<sup>rd</sup> portion of the scaphoid have less chances of fracture (20%) but have higher chances of AVN (40%).</span></p>",
      "correct_choice_id": 62378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13912,
      "choices": [
        {
          "id": 55609,
          "text": "<p><span style=\"font-size:12.0pt;\">Scalp, dura, arachnoid</span></p>"
        },
        {
          "id": 55610,
          "text": "<p><span style=\"font-size:12.0pt;\">Scalp, epicranium, endocranium and dura</span></p>"
        },
        {
          "id": 55611,
          "text": "<p><span style=\"font-size:12.0pt;\">Scalp, synchondral membrane, dura, arachnoid</span></p>"
        },
        {
          "id": 55612,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericranium, dura, arachnoid</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 6-month-old boy was brought to the casualty with seizures. The pediatrician tries to do CSF sampling. What are the structures punctured by the pediatrician while piercing through the marked structure? (</span>INICET May 2021)</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-63_Z2kvTec.jpg\" alt=\"\" width=\"273\" height=\"357\"></span></p>",
      "unique_key": "Q3949125",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506505,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Scalp, dura, arachnoid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The arrow in the illustration, which displays a baby's skull, is pointing in the direction of the anterior fontanelle. Ventricular tapping is the term used to describe the process of removing CSF from the anterior fontanelle. The various structures pierced are the scalp, dura, and arachnoid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fontanelle tap/ Percutaneous ventricular puncture:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infants who need urgent ventricular decompression and have an open anterior fontanelle and no access to a VP shunt undergo a fontanelle tap or percutaneous ventricular puncture. A butterfly needle is used to immediately puncture the infant's open fontanelle and enter the lateral ventricle in order to obtain CS samples, alleviate pressure, or insert a drain or catheter.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Procedure: A 25-gauge butterfly needle is inserted through the anterolateral aspect of the anterior fontanelle (away from the midline, avoiding the superior sagittal sinus).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When performing a fontanelle tap, the following layers are pierced:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Scalp</strong>: This includes the skin and the underlying connective tissue of the scalp.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Membranous fontanelle</strong>: The actual fontanelle is a soft spot on a baby's head where the bones of the skull have not yet fused together. It's a membranous gap between the cranial bones.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dura mater</strong>: The tough outermost membrane of the three layers of the meninges that surround the brain and spinal cord.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Arachnoid mater</strong>: A thin, wispy layer that lies underneath the dura mater.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cerebrospinal fluid (CSF)</strong>: Once through the arachanoid mater, the needle enters the subarachnoid space where the CSF is located.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note: The fontanelle tap bypasses the bony skull, which is why it's an accessible route in neonates and infants for procedures that require access to the CSF. However, as the child grows, these fontanelles close, and the method is no longer viable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fontanelle tap is a critical emergency procedure used in infants for CSF sampling or pressure relief from the ventricles, exploiting the unossified sections of the skull for direct access to the CSF. This procedure is unique to neonates and young infants where the fontanelle is present and typically involves piercing the scalp, dura, and arachnoid layers.</span></p>",
      "correct_choice_id": 55609,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10870,
      "choices": [
        {
          "id": 43446,
          "text": "<p><span style=\"font-size:12.0pt;\">Kwashiorkor due to less energy intake</span></p>"
        },
        {
          "id": 43447,
          "text": "<p><span style=\"font-size:12.0pt;\">Kwashiorkor due to less protein intake</span></p>"
        },
        {
          "id": 43448,
          "text": "<p><span style=\"font-size:12.0pt;\">Marasmus due to less energy intake</span></p>"
        },
        {
          "id": 43449,
          "text": "<p><span style=\"font-size:12.0pt;\">Marasmus due to less protein intake</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 3-year-old child is brought to the outpatient department by her grandmother Which of the following is correct about the given image? (FMGE JAN 2023)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/03/picture12_R0Qe0y5.jpg\" alt=\"\" width=\"300\" height=\"291\"></p>",
      "unique_key": "Q7313504",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506508,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Kwashiorkor due to less protein intake</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image is suggestive of kwashiorkor, as it shows a bulging abdomen and pedal edema along with thin limbs and prominent ribs. Kwashiorkor occurs as a result of less protein intake, whereas marasmus occurs due to less calorie intake.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-183804.jpg\" alt=\"\" width=\"1000\" height=\"300\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-183908.jpg\" alt=\"\" width=\"900\" height=\"524\"></strong></span></p>",
      "correct_choice_id": 43447,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13903,
      "choices": [
        {
          "id": 55573,
          "text": "<p><span style=\"font-size:12.0pt;\">T1 - T2</span></p>"
        },
        {
          "id": 55574,
          "text": "<p><span style=\"font-size:12.0pt;\">T2 - T3</span></p>"
        },
        {
          "id": 55575,
          "text": "<p><span style=\"font-size:12.0pt;\">T3 - T4</span></p>"
        },
        {
          "id": 55576,
          "text": "<p><span style=\"font-size:12.0pt;\">T4 - T5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the level of the cross-section shown in the image below. (</span>INICET Nov 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-103.jpg\" alt=\"\" width=\"325\" height=\"246\"></span></p>",
      "unique_key": "Q4894011",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506496,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. T4-T5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cross-section shown in the image is at the level of T4-T5.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ascending and Descending aorta are visible separately along with bifurcation of pulmonary trunk, this implies it is the section of T4-T5 level.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-104.jpg\" alt=\"\" width=\"600\" height=\"422\"></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options A, Option B:</strong> In cross-sections at the levels of T1-T2 and T2-T3, only the small vascular openings of the branches arising from the arch of aorta would be visible.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C: In cross section of T3-T4 level &nbsp;- </strong>section of arch of aorta along with branches of arch of aorta would be visible</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">Bifurcation of pulmonary trunk along with separate ascending and descending aorta are clearing pointing towards T4-T5 level.</span></p>",
      "correct_choice_id": 55575,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13888,
      "choices": [
        {
          "id": 55513,
          "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
        },
        {
          "id": 55514,
          "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
        },
        {
          "id": 55515,
          "text": "<p><span style=\"font-size:12.0pt;\">C</span></p>"
        },
        {
          "id": 55516,
          "text": "<p><span style=\"font-size:12.0pt;\">D</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following marked structures does not form part of the laryngeal skeleton? (</span><span style=\"font-size:11.0pt;\">INICET NOV 2020)</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><img class=\"image_resized\" style=\"aspect-ratio:654/859;width:37.76%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-03-27%20at%2011.30.59%20AM.jpeg\" width=\"654\" height=\"859\"></p>",
      "unique_key": "Q7474846",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506520,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The structure marked as 'A', is the hyoid bone, which is not a part of the laryngeal skeleton.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The hyoid bone is a U-shaped bone located at the base of the tongue. While it is not considered a part of the larynx itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The structures marked in the image are:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A - Hyoid bone</span></p><p><span style=\"font-size:12.0pt;\">B - Thyroid cartilage</span></p><p><span style=\"font-size:12.0pt;\">C - Epiglottis</span></p><p><span style=\"font-size:12.0pt;\">D - Cricoid cartilage</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Thyroid Cartilage:</strong> The thyroid cartilage is a large, shield-shaped cartilage in the larynx. It forms the prominent Adam's apple in the front of the neck and plays a role in sound production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Epiglottis:</strong> The epiglottis is a leaf-shaped cartilage &nbsp;which belongs to larynx located at the base of the tongue. Its primary function is to prevent food and liquids from entering the airway (trachea) during swallowing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cricoid Cartilage:</strong> The cricoid cartilage is a ring-shaped cartilage located just below the thyroid cartilage. It is the only complete ring of cartilage in the larynx and provides structural support to the airway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A set of cartilages that are joined by ligaments and fibrous membranes make up the laryngeal skeleton:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hyaline cartilage</strong>: The thyroid, cricoid, and the greater part of the arytenoid cartilages</span></li><li><span style=\"font-size:12.0pt;\"><strong>Elastic cartilage</strong>: The corniculate, cuneiform, tritiate, and epiglottic cartilages and the apices of the arytenoid cartilage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-90.jpg\" alt=\"\" width=\"700\" height=\"328\"></span></p>",
      "correct_choice_id": 55513,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55556,
      "choices": [
        {
          "id": 221677,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior cardiac vein</span></p>"
        },
        {
          "id": 221678,
          "text": "<p><span style=\"font-size:12.0pt;\">Great cardiac vein</span></p>"
        },
        {
          "id": 221679,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle cardiac vein</span></p>"
        },
        {
          "id": 221680,
          "text": "<p><span style=\"font-size:12.0pt;\">Small cardiac vein</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the marked structure: (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/31/screenshot-2024-08-31-101319.png\" alt=\"\" width=\"300\" height=\"440\"></span></p>",
      "unique_key": "Q5058726",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506530,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Great cardiac vein</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The marked structure in the provided image is the great cardiac vein. The great cardiac vein runs along the anterior interventricular sulcus, accompanying the anterior interventricular artery (also known as the left anterior descending artery or LAD). This vein collects blood from the anterior surfaces of both ventricles and drains into the coronary sinus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The great cardiac vein is the largest of the veins draining the heart muscle (myocardium), and it is crucial in returning deoxygenated blood from the myocardium to the coronary sinus and eventually into the right atrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anterior cardiac vein:</strong> These veins drain directly into the right atrium and do not run in the anterior interventricular sulcus. Therefore, this option is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Middle cardiac vein:</strong> This vein runs in the posterior interventricular sulcus, accompanying the posterior interventricular artery. It is not located in the anterior interventricular sulcus, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Small cardiac vein:</strong> This vein is located on the right side of the heart and accompanies the right coronary artery. It is not associated with the anterior interventricular sulcus, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The great cardiac vein runs along the anterior interventricular sulcus with the anterior interventricular artery and is crucial for draining blood from the anterior aspects of the heart.</span></p>",
      "correct_choice_id": 221678,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6521,
      "choices": [
        {
          "id": 26053,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        },
        {
          "id": 26054,
          "text": "<p><span style=\"font-size:12.0pt;\">Methysergide</span></p>"
        },
        {
          "id": 26055,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleomycin</span></p>"
        },
        {
          "id": 26056,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitrofurantoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is not likely to cause a pleural pathology? (NEET PG 2022)</span></p>",
      "unique_key": "Q9157054",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506527,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Metformin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metformin is an oral hypoglycemic agent used primarily in the treatment of type 2 diabetes mellitus. It works by decreasing hepatic glucose production and increasing insulin sensitivity. Metformin is not associated with pleural pathologies, making it the correct choice in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Methysergide</strong>: Methysergide is a medication used to prevent migraine headaches and is known for its potential to cause retroperitoneal and pleural fibrosis. This pleural pathology is a serious adverse effect, although the drug is not commonly used today due to this risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bleomycin</strong>: Bleomycin is a chemotherapeutic agent used in the treatment of various cancers. One of its well-known side effects is pulmonary toxicity, which can manifest as pulmonary fibrosis. Pleural involvement, including pleural effusions and fibrosis, can occur secondary to its pulmonary effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nitrofurantoin</strong>: Nitrofurantoin is an antibiotic used primarily for urinary tract infections. It can cause pulmonary reactions, including acute, subacute, and chronic pulmonary reactions. These reactions can involve the pleura, leading to pleural effusions and other pleural pathologies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metformin is not associated with causing pleural pathologies, unlike Methysergide, Bleomycin, and Nitrofurantoin, which have known risks of causing pleural and pulmonary complications.</span></p>",
      "correct_choice_id": 26053,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43264,
      "choices": [
        {
          "id": 172723,
          "text": "<p><span style=\"font-size:12pt;\">Opium</span></p>"
        },
        {
          "id": 172724,
          "text": "<p><span style=\"font-size:12pt;\">Marijuana</span></p>"
        },
        {
          "id": 172725,
          "text": "<p><span style=\"font-size:12pt;\">Cocaine</span></p>"
        },
        {
          "id": 172726,
          "text": "<p><span style=\"font-size:12pt;\">Magic mushroom</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">In 18<sup>th</sup> century British East India company used to transport which substance of abuse to China:&nbsp;</span>(INICET NOVEMBER 2023)</p>",
      "unique_key": "Q4310734",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506512,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Opium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Opium is derived from the poppy plant and has been used both medicinally and recreationally. In the 18th and 19th centuries, the British East India Company exported vast quantities of opium to China, leading to widespread addiction and the Opium Wars, which had significant geopolitical consequences.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Marijuana</strong>: A psychoactive drug from the Cannabis plant, used both recreationally and medicinally around the world.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cocaine</strong>: Derived from the coca plant, cocaine is a powerful stimulant used primarily as a recreational drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Magic Mushrooms</strong>: Refer to various types of mushrooms that contain psilocybin, a psychoactive compound. These have been used for centuries for their hallucinogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>In 18<sup>th</sup> century British East India company used to transport opium to China.</strong></span></p>",
      "correct_choice_id": 172723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5283,
      "choices": [
        {
          "id": 21104,
          "text": "<p><span style=\"font-size:12.0pt;\">Staphylococcus aureus</span></p>"
        },
        {
          "id": 21105,
          "text": "<p><span style=\"font-size:12.0pt;\">Clostridium botulinum</span></p>"
        },
        {
          "id": 21106,
          "text": "<p><span style=\"font-size:12.0pt;\">Clostridium perfringes</span></p>"
        },
        {
          "id": 21107,
          "text": "<p><span style=\"font-size:12.0pt;\">Salmonella typhi</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old boy presents with a history of vomiting within 3 hours of consumption of food at a party. Which of the following organism is most likely to cause these symptoms?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">NEET PG 2020)</span></p>",
      "unique_key": "Q5529098",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506517,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Staphylococcus aureus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most likely causative organism in the given scenario is Staphylococcus aureus. It causes food poisoning <strong>within 30 minutes to 6 hours</strong> after consumption of the contaminated food.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The common sources of infection are the foods that are not cooked after handling. These include sliced meats, puddings, <strong>pastries,</strong> and sandwiches. Patients present with nausea, vomiting, stomach cramps, and diarrhoea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Clostridium botulinum:</strong> Causes botulism, typically presenting with symptoms such as muscle weakness, paralysis, and respiratory failure rather than rapid-onset vomiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clostridium perfringens:</strong> Associated with gastroenteritis that causes abdominal cramps and diarrhea, typically occurring 8-16 hours after consumption of contaminated food.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Salmonella typhi:</strong> Causes typhoid fever, characterized by prolonged fever, abdominal pain, and other systemic symptoms, rather than immediate vomiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/24/screenshot-2024-06-24-182540.png\" alt=\"\" width=\"1000\" height=\"662\"></strong></span></p>",
      "correct_choice_id": 21104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54916,
      "choices": [
        {
          "id": 219125,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior turbinate</span></p>"
        },
        {
          "id": 219126,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferior turbinate</span></p>"
        },
        {
          "id": 219127,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle turbinate</span></p>"
        },
        {
          "id": 219128,
          "text": "<p><span style=\"font-size:12.0pt;\">Supreme turbinate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Sludder’s neuralgia is due to compression of anterior ethmoidal nerve by septal spur in the region of: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q4308341",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506500,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) Middle turbinate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sludder’s neuralgia, also known as anterior ethmoidal neuralgia, occurs due to the compression of the anterior ethmoidal nerve. This nerve provides sensory innervation to parts of the nasal cavity and the anterior part of the cranial cavity. A septal spur, which is a sharp bony projection from the nasal septum, can impinge on the middle turbinate where the anterior ethmoidal nerve traverses. This compression can cause pain and headache in the regions supplied by the nerve, commonly leading to facial pain and nasal discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Superior turbinate</strong>: While the superior turbinate is located higher in the nasal cavity, it is not typically involved in the compression causing Sludder’s neuralgia. The anterior ethmoidal nerve runs closer to the middle turbinate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Inferior turbinate</strong>: The inferior turbinate is situated lower in the nasal cavity and does not typically come into contact with the septal spur affecting the anterior ethmoidal nerve. Therefore, it is not involved in Sludder’s neuralgia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Supreme turbinate</strong>: The supreme turbinate is an anatomical variant that some individuals have above the superior turbinate. This is not commonly implicated in conditions involving the anterior ethmoidal nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sludder’s neuralgia, or anterior ethmoidal neuralgia, is caused by the compression of the anterior ethmoidal nerve by a septal spur in the region of the middle turbinate. This condition results in facial pain and headache due to nerve irritation.</span></p>",
      "correct_choice_id": 219127,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5929,
      "choices": [
        {
          "id": 23686,
          "text": "<p><span style=\"font-size:12pt;\">Chronic renal disease</span></p>"
        },
        {
          "id": 23687,
          "text": "<p><span style=\"font-size:12pt;\">Thromboembolism</span></p>"
        },
        {
          "id": 23688,
          "text": "<p><span style=\"font-size:12pt;\">History of amenorrhea</span></p>"
        },
        {
          "id": 23689,
          "text": "<p><span style=\"font-size:12pt;\">Diabetes mellitus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is an absolute contraindication to OCP use?</span><span style=\"font-size:12.0pt;\"> (NEET PG 2019)</span></p>",
      "unique_key": "Q4374016",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506534,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Thromboembolism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Thromboembolism is an absolute contraindication to the use of Oral Contraceptive Pills (OCPs). The use of combined oral contraceptives (COCs) can significantly increase the risk of venous thromboembolism, particularly in individuals with a history of thromboembolic events or known thrombogenic mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Absolute Contraindications of Combined OCPs according to the WHO Medical Eligibility Criteria:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>MEC Category 4:</strong> Unacceptable health risk if the method is used.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Breastfeeding and &lt; 6 weeks postpartum</span></li><li><span style=\"font-size:12pt;\">Not breastfeeding; &lt; 21 days postpartum with risk factors for Venous Thromboembolism</span></li><li><span style=\"font-size:12pt;\">Age ≥ 35 years with smoking ≥ 15 cigarettes/day</span></li><li><span style=\"font-size:12pt;\">Hypertension with systolic BP ≥ 160 OR Diastolic BP ≥ 100 mmHg</span></li><li><span style=\"font-size:12pt;\">Hypertension with vascular disease</span></li><li><span style=\"font-size:12pt;\">History of DVT/Pulmonary embolism</span></li><li><span style=\"font-size:12pt;\">Acute DVT/Pulmonary embolism</span></li><li><span style=\"font-size:12pt;\">DVT/Pulmonary embolism on anticoagulant therapy</span></li><li><span style=\"font-size:12pt;\">Major surgery with prolonged immobilization</span></li><li><span style=\"font-size:12pt;\">Known thrombogenic mutations (e.g., Factor V Leiden, prothrombin mutation, protein S, C, antithrombin deficiency)</span></li><li><span style=\"font-size:12pt;\">Current and history of ischemic heart disease</span></li><li><span style=\"font-size:12pt;\">Stroke (history of cerebrovascular disease)</span></li><li><span style=\"font-size:12pt;\">Complicated valvular heart disease</span></li><li><span style=\"font-size:12pt;\">Antiphospholipid Antibody Syndrome</span></li><li><span style=\"font-size:12pt;\">Migraine with aura (any age)</span></li><li><span style=\"font-size:12pt;\">Current breast cancer</span></li><li><span style=\"font-size:12pt;\">Severe cirrhosis</span></li><li><span style=\"font-size:12pt;\">Hepatocellular adenoma/carcinoma</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Chronic Renal Disease</strong>: Chronic renal disease is not an absolute contraindication but requires careful consideration depending on the severity and associated conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. History of Amenorrhea</strong>: A history of amenorrhea is not an absolute contraindication to the use of OCPs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Diabetes Mellitus</strong>: Diabetes mellitus is not an absolute contraindication. However, it requires careful monitoring, especially if the patient has vascular complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Thromboembolism is an absolute contraindication to the use of combined oral contraceptives (COCs) due to the increased risk of venous thromboembolism associated with these medications.</span></p><p>&nbsp;</p>",
      "correct_choice_id": 23687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9913,
      "choices": [
        {
          "id": 39618,
          "text": "<p><span style=\"font-size:12pt;\">Poikiloderma</span></p>"
        },
        {
          "id": 39619,
          "text": "<p><span style=\"font-size:12pt;\">Salt and pepper pigmentation</span></p>"
        },
        {
          "id": 39620,
          "text": "<p><span style=\"font-size:12pt;\">Leukotrichia</span></p>"
        },
        {
          "id": 39621,
          "text": "<p><span style=\"font-size:12pt;\">Vitiligo</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The patient visiting the outpatient department exhibits skin manifestations linked to a disease that includes Raynaud’s phenomenon. What is this skin manifestation shown below? (INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/picture6_oxDdSH2.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p>",
      "unique_key": "Q5559122",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506507,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Salt and pepper pigmentation.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The presented clinical scenario indicates <strong>systemic sclerosis</strong>, a complex <strong>autoimmune</strong> condition of uncertain origin with diverse clinical manifestations.</span></li><li><span style=\"font-size:12pt;\">It leads to considerable <strong>disability</strong> and <strong>mortality</strong>, affecting nearly <strong>all organs</strong>.</span></li><li><span style=\"font-size:12pt;\">The defining feature of systemic sclerosis is <strong>scleroderma</strong>, characterized by <strong>thickened</strong> and <strong>indurated</strong> <strong>skin</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Systemic sclerosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">It also presents with typical skin manifestations of <strong>Raynaud </strong>phenomenon, which include the characteristic <strong>white discoloration </strong>of the <strong>fingers</strong> due to vasospasm and <strong>bluish </strong>discoloration of the fingertips as shown in the image below.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3433.jpg\" alt=\"\" width=\"300\" height=\"334\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The skin has a <strong>salt-and-pepper appearance</strong> when there is a loss of pigmentation, which is most noticeable on the <strong>upper back</strong> (as given in the question), chest, and scalp.</span></li><li><span style=\"font-size:12pt;\"><strong>Sclerodactyly</strong> and sclerosis extending proximal to the metacarpophalangeal joints with or without contractures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3566.jpg\" alt=\"\" width=\"300\" height=\"227\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Loss of fingertip pulp</span></li><li><span style=\"font-size:12pt;\"><strong>Vasculopathic ulcers</strong> over the bony prominences</span></li><li><span style=\"font-size:12pt;\">Puffy fingers in early disease</span></li><li><span style=\"font-size:12pt;\">Severe flexion <strong>contractures</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Expressionless facies</strong>, mat-like telangiectasias, microstomia, perioral furrowing, and a beak-like nose can be seen as shown in the image below</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture36.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Poikiloderma is a skin disorder characterized by (ATP)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Atrophy</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Telangiectasias</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Pigment</strong> abnormalities Hypo and hyper</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3733.jpg\" alt=\"\" width=\"250\" height=\"394\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">It is seen in ionizing radiation-damaged skin and <strong>Dermatomyositis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;</strong>Sometimes the color of the hair can change to white in the amelanotic lesions of vitiligo. <strong>It is known as leukotrichia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;</strong>Sharply demarcated <strong>depigmented macules are a hallmark of vitiligo</strong>. It results from the loss of melanocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3866.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>'Salt and Pepper pigmentation'&nbsp;</strong>is a cutaneous manifestation often seen in <strong>systemic</strong> <strong>sclerosis</strong>, a condition which also commonly presents with <strong>Raynaud’s</strong> phenomenon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 56 page no 56.4</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison’s principles of internal medicine, 21<sup>st</sup> edition 2779</strong></span></p>",
      "correct_choice_id": 39619,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1302,
      "choices": [
        {
          "id": 5203,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Head</span></p>"
        },
        {
          "id": 5204,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Cervical spine</span></p>"
        },
        {
          "id": 5205,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Limbs</span></p>"
        },
        {
          "id": 5206,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Abdomen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Whole- body CT scan protocol for a trauma patient includes all, except? (INICET NOV 2022)</span></p>",
      "unique_key": "Q4256918",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506532,
      "difficulty_level": "beginner",
      "subjects_id": [
        17
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) CT limbs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CT Limbs is not included in the whole-body CT of a trauma patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CT Head:</strong> Non-contrast CT (NCCT) of the head to check for any intracranial hemorrhages or fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CT Cervical Spine:</strong> NCCT of the cervical spine to assess for any fractures or dislocations that may compromise the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CT Abdomen:</strong> Contrast-enhanced CT of the torso, including the abdomen and pelvis, to evaluate for internal injuries such as organ lacerations, bleeding, or other trauma-related abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Whole-body CT or trauma CT includes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">NCCT head</span></li><li><span style=\"font-size:12.0pt;\">NCCT C-spine</span></li><li><span style=\"font-size:12.0pt;\">Contrast-enhanced CT of torso</span></li></ol>",
      "correct_choice_id": 5205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20912,
      "choices": [
        {
          "id": 83612,
          "text": "<p><span style=\"font-size:12.0pt;\">N-acetyl cysteine to replenish glutathione stores</span></p>"
        },
        {
          "id": 83613,
          "text": "<p><span style=\"font-size:12.0pt;\">Pralidoxime</span></p>"
        },
        {
          "id": 83614,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucagon to control bradycardia and hypoglycemia</span></p>"
        },
        {
          "id": 83615,
          "text": "<p><span style=\"font-size:12.0pt;\">Give sodium bicarbonate to alkalize urine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young female is brought to the emergency department. Attendants inform that she has consumed 100 tablets of aspirin. What should be the next step in management? (NEET PG 2023)</span></p>",
      "unique_key": "Q9843767",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506531,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Give sodium bicarbonate to alkalize urine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Aspirin poisoning (Salicylism)</strong></span></p><p>&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">Respiratory Center Stimulation</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">Hyperventilation</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓CO<sub>2</sub></span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">Respiratory Alkalosis → Reversible</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">↓</span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\">Metabolic Acidosis → Irreversible</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment - DOC is sodium bicarbonate (NaHC03)</span></p><ul><li><span style=\"font-size:12.0pt;\">&nbsp;Reverses metabolic acidosis</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;Helps in aspirin excretion</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. N-acetyl cysteine to replenish glutathione stores</strong>: N-acetyl cysteine is an antidote for paracetamol poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong></span><span style=\"font-size:11pt;\"><strong>.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Pralidoxime</strong>: Pralidoxime is useful in organophosphate poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong></span><span style=\"font-size:11pt;\"><strong>.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Glucagon to control bradycardia and hypoglycemia</strong>: Glucagon is antidote in beta-blocker toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sodium Bicarbonate</strong> is the treatment of choice in aspirin poisoning, as it helps to alkalize the urine and enhance the excretion of salicylates, while also correcting metabolic acidosis.</span></p>",
      "correct_choice_id": 83615,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2547,
      "choices": [
        {
          "id": 10173,
          "text": "<p><span style=\"font-size:12.0pt;\">W, X, Y</span></p>"
        },
        {
          "id": 10174,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿W, Z</span></p>"
        },
        {
          "id": 10175,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿WX</span></p>"
        },
        {
          "id": 10176,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿W Y</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The illustration below shows alternative splicing of a gene which has intron segments 1, 2, 3, 4, and 5. It yields two products A and B, by the action of different promoters. You are provided with the promoters W, X, Y, and Z, each of which binds to a different segment as shown below and acts in the marked direction. Which of the following promoters will you use to get product A? (INICET Nov 2020)</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><img class=\"image_resized\" style=\"aspect-ratio:400/235;width:90.94%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/06/whatsapp-image-2023-06-12-at-190121011090.jpg\" alt=\"\" width=\"400\" height=\"235\"></p>",
      "unique_key": "Q7280025",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506522,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. W Y</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A promoter is a region of DNA upstream of a gene where relevant proteins bind to initiate</span></p><p><span style=\"font-size:12.0pt;\">transcription of that gene. In the case of this question, product A is formed by including specific</span></p><p><span style=\"font-size:12.0pt;\">segments and excluding others through the process of alternative splicing.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Sequence A consists of segments 1, 3, 4, and 5.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Promoter W Required for segment 1.</span></li><li><span style=\"font-size:12.0pt;\">Promoter Y Required for segments 3, 4, and 5.</span></li><li><span style=\"font-size:12.0pt;\">Segment 2 is excluded during alternative splicing.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, the combination of Promoters W and Y will result in the production of sequence A by including</span></p><p><span style=\"font-size:12.0pt;\">the correct segments and excluding segment 2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:12.0pt;\"><strong>Option a (W, X, Y)</strong>: This combination Required Promoter X, for segment 2, but it</span></p><p><span style=\"font-size:12.0pt;\">is unnecessary since W and Y alone are sufficient to yield product A.</span></p></li><li><span style=\"font-size:12.0pt;\"><strong>Option b (W, Z)</strong>: Promoter Z does not include segments 3, making this option incorrect for generating product A.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option c (WX)</strong>: Promoters W and X are insufficient because they do not include segments 3, 4, and 5, which are essential for product A.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A promoter is a region of DNA upstream of a gene where relevant proteins bind to initiate</span></p><p><span style=\"font-size:12.0pt;\">transcription of that gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Using promoters W, Y will yield product A by including segments 1, 3, 4, and 5 and removing segment 2 through alternative splicing.</span></p>",
      "correct_choice_id": 10176,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24688,
      "choices": [
        {
          "id": 98713,
          "text": "<p><span style=\"font-size:12.0pt;\">Incorrect antigen</span></p>"
        },
        {
          "id": 98714,
          "text": "<p><span style=\"font-size:12.0pt;\">Incorrect antibody</span></p>"
        },
        {
          "id": 98715,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibody excess</span></p>"
        },
        {
          "id": 98716,
          "text": "<p><span style=\"font-size:12.0pt;\">Antigen excess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with a prolonged fever of unknown origin (PUO), raising suspicion of brucellosis. To confirm the diagnosis, various dilutions of the patient's serum sample are prepared for a standard agglutination test. The outcome is as follows: No agglutination is observed at serum dilutions of 1:20 and 1:40, while positive agglutination occurs at dilutions of 1:80 and 1:160. What factor is accountable for the lack of agglutination in the initial two dilutions? (INICET MAY 2023)</span></p>",
      "unique_key": "Q6844631",
      "question_audio": null,
      "question_video": null,
      "map_id": 20506516,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Antibody excess</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Marrack proposed the lattice hypothesis →</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Multivalent antigens combine with Bivalent antibodies</span></li><li><span style=\"font-size:12.0pt;\">Lattice is formed only when antigen and antibodies are in proportion.</span></li><li><span style=\"font-size:12.0pt;\">If&nbsp;antigen or antibodies ,any of them is in excess - there is no lattice formation</span></li><li><span style=\"font-size:12.0pt;\">The absence of a positive test result in the initial two tubes can be attributed to the prozone phenomenon.</span></li><li><span style=\"font-size:12.0pt;\">In this scenario, there is an excess of antibodies in comparison to antigens, which results in a lack of robust or noticeable precipitation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Zone phenomenon:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Prozone = Ab excess = Absent</span></li><li><span style=\"font-size:12.0pt;\">Zone of equivalence = Proper proportion = Peak</span></li><li><span style=\"font-size:12.0pt;\">Post zone = Ag excess = Absent</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125643.jpg\" alt=\"\" width=\"700\" height=\"298\"></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-150704.png\" alt=\"\" width=\"500\" height=\"316\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Incorrect antigen:</strong> If the antigen were incorrect, there would be no agglutination at any dilution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Incorrect antibody:</strong> If the antibody were incorrect, there would be no agglutination at any dilution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antigen excess:</strong> Antigen excess would cause a postzone phenomenon, not observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The prozone phenomenon, where antibody excess prevents agglutination, can account for the lack of agglutination in low dilution samples.</span></p>",
      "correct_choice_id": 98715,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}